I think you're spot on with that observation, Synaphai.....
Also, it's not just US investors who invest in the NASDAQ, it is essentially the whole universe of investors, so rich investors from US, China, Japan, UK, EU.....
The way our IP and product is valued by Aus investors is a joke and not a funny one..... this is a once in a generation, perhaps once in a lifetime med tech product which has a very good chance of earning whoever controls in US$10's of Billions going forward and we're valued at AU$300 million, come one, enough is enough. This NASDAQ listing cannot come fast enough, so at least we'll get an opportunity to be fairly valued eventually.
AVR Price at posting:
$15.00 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)